Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYTHS-MR
2022-501547-33-01Phase 4Authorised
- Sponsor
- Antwerp University Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, single-blind trial in acute myocarditis comparing Pulsed intravenous methylprednisolone with Placebo plus standard therapy (2 arms). Planned start Dec 2024; status: authorised.
02
Drugs
methylprednisolone
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2022-501547-33-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501547-33-01.